GJA1 and atrial fibrillation: In AF rat models, SLFM has been shown to inhibit atrial fibrosis and the inflammatory response, upregulate the expression of Cx43 to prevent both electrical and structural remodeling of the atria, and suppress the onset and progression of AF.